Identification of LncRNA Mhrt as a potential biomarker for preventing the progression of Myocardial Ischemia-Reperfusion Injury through bioinformatics and experimental validation

通过生物信息学和实验验证,鉴定出长链非编码RNA Mhrt作为预防心肌缺血再灌注损伤进展的潜在生物标志物。

阅读:1

Abstract

OBJECTIVE: This study aimed to identify biomarkers associated with MIRI and elucidate their potential mechanisms through integrated bioinformatics and experimental validation. METHODS: snRNA-seq data (GSE227088) from MIRI samples underwent batch effect removal and quality control to construct a nuclear landscape. Cell type-specific clusters (cardiomyocyte-enriched cluster) were identified by comparing cell proportions between Sham and MIRI groups. Differential expression analysis revealed the lncRNA Mhrt as significantly upregulated in cardiomyocyte cluster (avg_log2FC > 2). Single-gene GSEA and pseudotime trajectory analyses were performed to explore lncRNA Mhrt’s role in MIRI progression. Subsequently, in the microarray dataset (GSE160516), genes associated with lncRNA Mhrt were identified using WGCNA, followed by enrichment analysis. The diagnostic efficacy of lncRNA Mhrt was evaluated based on the AUC of the ROC curve and its differential expression between the Sham and MIRI groups, and validated by qRT-PCR. RESULTS: In GSE227088, MIRI-related cardiomyocyte cluster and the significantly expressed lncRNA Mhrt (|avg_log2FC| >2) were identified. Enrichment analysis suggested its potential role in regulating mitochondrial functions such as oxidative phosphorylation to influence MIRI pathogenesis. Pseudotime analysis indicated its possible involvement in cardiomyocyte redifferentiation. Validation in GSE160516 showed that lncRNA Mhrt had extremely high diagnostic efficacy in distinguishing between the Sham and MIRI groups (ROC curve AUC = 1) with significant intergroup expression differences, which was further validated by qRT-PCR. CONCLUSION: This study highlights lncRNA Mhrt as a potential biomarker for MIRI, implicating its regulatory role in oxidative phosphorylation-mediated pathological processes. These findings advance understanding of MIRI mechanisms and provide a foundation for therapeutic development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-025-05324-0.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。